AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RALTEGRAVIR
9 registrations across 4 African markets— 6 active
Markets with RALTEGRAVIR
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ISENTRESS TABLET; ORAL | 🇿🇼Zimbabwe | MSD PTY LTD | active | Jun 2030 |
| ISENTRESS TABLET; ORAL | 🇿🇼Zimbabwe | MSD PTY LTD | active | Jun 2030 |
| ISENTRESS TABLET; ORAL | 🇿🇼Zimbabwe | MSD PTY LTD | active | Dec 2027 |
| ISENTRESS_100MG 100MG CHEWABLE TABLET CHEWABLE TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ISENTRESS_25MG 25MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ISENTRESS 400MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| Isentress 25 mg Tablets, Chewable | 🇹🇿Tanzania | MSD (PTY) LTD | active | — |
| ISENTRESS COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| Isentress 100 mg Tablets, Chewable | 🇹🇿Tanzania | MSD (PTY) LTD | active | — |
RALTEGRAVIR in Africa — Regulatory Overview
RALTEGRAVIR is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Zimbabwe, Tanzania, Morocco. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.